Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley fever virus in Ugandan bats

Rebekah C. KadingDivision of Vector-borne Diseases, Arbovirus Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USA;Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USACorrespondence[email protected]
View further author information

Robert M. KityoDepartment of Biological Sciences, Makerere University, Kampala, UgandaView further author information

Eric C. MosselDivision of Vector-borne Diseases, Arbovirus Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USAView further author information

Erin M. BorlandDivision of Vector-borne Diseases, Arbovirus Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USAView further author information

Teddie NakayikiDepartment of Arbovirology, Emerging, and Re-emerging Viral Infections, Uganda Virus Research Institute, Entebbe, UgandaView further author information

Betty NalikkaDepartment of Biological Sciences, Makerere University, Kampala, UgandaView further author information

Luke NyakarahukaDepartment of Arbovirology, Emerging, and Re-emerging Viral Infections, Uganda Virus Research Institute, Entebbe, Uganda

http://orcid.org/0000-0002-2944-9157 View further author information

Jeremy P. LedermannDivision of Vector-borne Diseases, Arbovirus Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USAView further author information

Nicholas A. PanellaDivision of Vector-borne Diseases, Arbovirus Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USAView further author information

Amy T. GilbertDivision of High Consequence Pathogens, Rabies and Poxvirus Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA;USA Department of Agriculture, Animal and Plant Health Inspection Service, Fort Collins, CO, USAView further author information

Mary B. CrabtreeDivision of Vector-borne Diseases, Arbovirus Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USAView further author information

Julian Kerbis PeterhansCollege of Professional Studies, Roosevelt University & Collections & Research, The Field Museum of Natural History, Chicago, IL, USAView further author information

Jonathan S. TownerDivision of High Consequence Pathogens, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA

http://orcid.org/0000-0002-6473-3049 View further author information

Brian R. AmmanDivision of High Consequence Pathogens, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Tara K. SealyDivision of High Consequence Pathogens, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Stuart T. NicholDivision of High Consequence Pathogens, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Ann M. PowersDivision of Vector-borne Diseases, Arbovirus Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USAView further author information

Julius J. LutwamaDepartment of Arbovirology, Emerging, and Re-emerging Viral Infections, Uganda Virus Research Institute, Entebbe, UgandaView further author information

Barry R. MillerDivision of Vector-borne Diseases, Arbovirus Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USAView further author information

show all

Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley fever virus in Ugandan bats

Table 1. Species and sampling locations for bat sera tested, Uganda 2009, and 2011–2013.

Table 2. Prevalence of neutralizing antibodies detected in Ugandan bats, 2009 – 2013. Number positive/number tested for each virus in each location and year.

Table 3. Example end-point titers of arbovirus neutralizing antibodies (PRNT₈₀). The top five lines represent bats for which a specific result was determined; the bottom five lines represent bats for which serological results were inconclusive.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley fever virus in Ugandan bats

Figures & data

Table 1. Species and sampling locations for bat sera tested, Uganda 2009, and 2011–2013.

Table 2. Prevalence of neutralizing antibodies detected in Ugandan bats, 2009 – 2013. Number positive/number tested for each virus in each location and year.

Table 3. Example end-point titers of arbovirus neutralizing antibodies (PRNT80). The top five lines represent bats for which a specific result was determined; the bottom five lines represent bats for which serological results were inconclusive.

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 3. Example end-point titers of arbovirus neutralizing antibodies (PRNT₈₀). The top five lines represent bats for which a specific result was determined; the bottom five lines represent bats for which serological results were inconclusive.